GREY:ICOTF - Post by User
Comment by
stockgurukingon Oct 31, 2012 10:40am
228 Views
Post# 20543972
RE: RE: Something is UP
RE: RE: Something is UP The company has repeatedly publicly stated that Interim Phase II data will be announced in H2-2012. Most recently in the update they circultated in October. The full data set is due sometime in H2-2013 - most likely October/November as per the the Trials official Record Detail which states the estimated primary completion date is September 2013. For a detailed record visit:
*
https://www.clinicaltrials.gov/ct2/show/NCT01565148?term=ico+therapeutics&rank=2
*
Financed below market? Please provide an example of a company in the space that has financed at a premium in the past 12 months. Note that JDRF (the worlds largest funder of diabetes research) is iCo's partner for the trial and has every optical (no pun intended) reason to ensure the trial is a success...the potential to "expand" this relationship exists. Also, the company brought in $1.1 million non-dillutive from the Canadian government and the Gates Foundation for a "non-core" asset.
*
Other catalysts:
- Regional partnership on 007
- Further development of 009 via non-dillutive funding and potential partnerships
- Going public event for 008 partner - Immune Pharamaceuticals is currently in the midst of listing on a US exchange and doing a large raise ($20-30 million). ICO is owed seven figure milestones on this asset as early as H1 next year.